News
Imagine treating a genetic disease not by managing symptoms for life, but by correcting the underlying genetic error itself. Inventors at NIH are advancing that vision with a gene editing technology designed to deliver highly precise genetic corrections, opening new possibilities for therapies that
Dr. Jorge Munoz will discuss the CDC Trioplex real-time RT-PCR assay for detection and differentiation of Zika, dengue and chikungunya virus infections in one clinical sample. To participate, please pre-register by sending an email to tto@cdc.gov by Thursday, April 26, at 1 p.m. EDT. After
Health and Human Services (HHS) tops Reuters’ second annual ranking of the Top 25 Global Innovators – Government, a list that identifies and ranks the publicly funded institutions doing the most to advance science and technology. The rankings were compiled in partnership with Clarivate Analytics
Klebsiella bacteria cause about 10 percent of all hospital-acquired infections in the United States. A carbapenem-resistant K. pneumoniae strain known as multilocus sequence type 258 (ST258) is one of the antibiotic-resistant organisms labeled an urgent threat by the Centers for Disease Control and